SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053270
Filing Date
2020-11-12
Accepted
2020-11-12 07:16:12
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr-10q_20200930.htm   iXBRL 10-Q 2749974
2 EX-31.1 tcrr-ex311_6.htm EX-31.1 10675
3 EX-31.2 tcrr-ex312_7.htm EX-31.2 10630
4 EX-32.1 tcrr-ex321_8.htm EX-32.1 9552
5 GRAPHIC gradu2zr5yd4000001.jpg GRAPHIC 2978
  Complete submission text file 0001564590-20-053270.txt   7660171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20200930.xsd EX-101.SCH 41662
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcrr-20200930_cal.xml EX-101.CAL 39461
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcrr-20200930_def.xml EX-101.DEF 122172
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20200930_lab.xml EX-101.LAB 366767
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20200930_pre.xml EX-101.PRE 263755
11 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-10q_20200930_htm.xml XML 1210661
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 201303343
SIC: 2836 Biological Products, (No Diagnostic Substances)